Vimarsana
Biggest News Aggregation in the World

Page 2 - Bio Call News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Bio Call. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Bio Call Today - Breaking & Trending Today

Provention Bio to Report First Quarter 2022 Financial Results on May 5, 2022 - Vimarsana News

Provention Bio to Report First Quarter 2022 Financial Results on May 5, 2022

Published: April 28, 2022

/PRNewswire/ -- Provention Bio, Inc. (Nasdaq: PRVB), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated disease, today...

Source: prnewswire.com
Related Topics:
Robert DoodyProvention Bio IncPrnewswire Provention Bio IncBio CallProvention Bio
Provention Bio Resubmitting Biologics License Application for Delay of Clinical Type 1 Diabetes in At-Risk Individuals Following Type B Meeting with the FDA - Vimarsana News

Provention Bio Resubmitting Biologics License Application for Delay of Clinical Type 1 Diabetes in At-Risk Individuals Following Type B Meeting with the FDA

Published: January 27, 2022

/PRNewswire/ -- Provention Bio, Inc. (Nasdaq: PRVB) (the "Company"), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated...

Source: prnewswire.com
Related Topics:
Lori RosenRobert DoodyAshleigh PalmerProvention BioExchange CommissionProvention Bio IncPrnewswire Provention Bio IncDrug AdministrationBiologics License ApplicationTherapy DesignationPriority ReviewWebcast InformationBio CallLooking Statements
Provention Bio Resubmitting Biologics License Application for Delay of Clinical Type 1 Diabetes in At-Risk Individuals Following Type B Meeting with the FDA - Vimarsana News

Provention Bio Resubmitting Biologics License Application for Delay of Clinical Type 1 Diabetes in At-Risk Individuals Following Type B Meeting with the FDA

Published: January 27, 2022

/PRNewswire/ -- Provention Bio, Inc. (Nasdaq: PRVB) (the "Company"), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated...

Source: prnewswire.com
Related Topics:
Lori RosenRobert DoodyAshleigh PalmerProvention BioExchange CommissionProvention Bio IncPrnewswire Provention Bio IncDrug AdministrationBiologics License ApplicationTherapy DesignationPriority ReviewWebcast InformationBio CallLooking Statements
Provention Bio Reports Third Quarter 2021 Financial Results and Provides Business Update - Vimarsana News

Provention Bio Reports Third Quarter 2021 Financial Results and Provides Business Update

Published: November 4, 2021

/PRNewswire/ -- Provention Bio, Inc. (Nasdaq: PRVB), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated disease, today...

Source: prnewswire.com
Related Topics:
Lori RosenSam MartinRobert DoodyAshleigh PalmerProvention BioExchange CommissionProvention Bio IncDrug AdministrationChief Executive OfficerComplete Response LetterRecent Corporate HighlightsBiologics License ApplicationClinical TypeEvaluating TeplizumabRecent Onset TypeTrial EvaluatingSystemic LupusNon Responsive CeliacSerious Adverse EventsAdverse EventsSpecial InterestLicense AgreementWebcast InformationBio CallLooking Statements
Provention Bio to Report Third Quarter 2021 Financial Results on November 4, 2021 - Vimarsana News

Provention Bio to Report Third Quarter 2021 Financial Results on November 4, 2021

Published: October 28, 2021

/PRNewswire/ -- Provention Bio, Inc. (Nasdaq: PRVB), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated disease, today...

Source: prnewswire.com
Related Topics:
Lori RosenSam MartinRobert DoodyProvention Bio IncPrnewswire Provention Bio IncBio CallProvention Bio